EUVIMEDEUVIMED entdecken
Crossref

Utilization of Indocyanine Green for Augmentation of Pulmonary Metastases Resection in Pediatric, Adolescent, and Young Adult Sarcoma Patients

Sophia M V Schermerhorn iD, Emily Vore, Alexander J Bondoc, Todd Jenkins, Roshni Dasgupta

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Sophia M V Schermerhorn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Indocyanine Green, Lung Neoplasms, Sarcoma, Metastasectomy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Complete pulmonary metastasectomy is central to curative‐intent therapy for sarcoma, but lesion localization can be challenging. Indocyanine green (ICG) near‐infrared fluorescence offers real‐time intraoperative guidance, though data in pediatric and adolescent/young adult sarcoma patients are limited.

Methods

A retrospective review of patients with metastatic sarcoma who underwent pulmonary metastasectomy was performed. Patients were dosed preoperative ICG (dose: 4 mg/kg, 24 h before surgery) between April 2019 and November 2022. Demographics, tumor histology, operative details, lesion characteristics, and ICG status were analyzed. Sensitivity, positive predictive value (PPV), and the proportion of lesions identified solely by ICG were calculated.

Results

Thirty‐one patients aged 6–42 years underwent 51 pulmonary metastasectomies. Overall sensitivity of ICG for detecting metastatic lesions was 81.0% with a PPV of 39.0%. ICG identified 17.0% of metastases not palpable or visible on inspection. Patients with prior lung radiation demonstrated lower sensitivity at 64.0% than the overall cohort. No adverse reactions to ICG were observed.

Conclusion

ICG fluorescence imaging is a safe adjunct to pulmonary metastasectomy in pediatric, adolescent, and young adult sarcoma patients. It facilitates more complete resection by identifying additional lesions not detected with standard techniques without significant adverse effects. These findings support use of ICG as a complement to meticulous surgical exploration. Further multicenter studies are needed to assess its impact on oncologic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Indocyanine GreenLung NeoplasmsSarcomaMetastasectomyOptical ImagingHumansAdolescentFemaleChildMaleYoung AdultRetrospective StudiesAdultPrognosisFollow-Up Studies

Stichwörter der Autor:innen

fluorescent guided surgeryindocyanine greenpediatric patientspulmonary metastasectomysarcoma

Substanzen

Indocyanine Green

Autor:innen und Institutionen

  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

ORCID-Profile: Sophia M V Schermerhorn

Zitieren

APA

Schermerhorn, S. M. V., Vore, E., Bondoc, A. J., Jenkins, T., & Dasgupta, R. (2026). Utilization of Indocyanine Green for Augmentation of Pulmonary Metastases Resection in Pediatric, Adolescent, and Young Adult Sarcoma Patients. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70096

Vancouver

Schermerhorn SMV, Vore E, Bondoc AJ, Jenkins T, Dasgupta R. Utilization of Indocyanine Green for Augmentation of Pulmonary Metastases Resection in Pediatric, Adolescent, and Young Adult Sarcoma Patients. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70096

BibTeX
@article{Schermerhorn2026,
  author = {Schermerhorn, Sophia M V and Vore, Emily and Bondoc, Alexander J and Jenkins, Todd and Dasgupta, Roshni},
  title = {Utilization of Indocyanine Green for Augmentation of Pulmonary Metastases Resection in Pediatric, Adolescent, and Young Adult Sarcoma Patients},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70096}
}
Kostenlos starten →